ESHRE. Metformin treatment reduces ovarian cytochrome P -450c17α response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome

By  

Human Reproduction, Vol. 15, Iss. 3, 2000-03 ,pp. : 736-736

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin

By Koivunen Riitta M.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2546-2551

Oxford University Press

Access to resources Recommend Favorite

The Regulation of Human P450c17 Activity: Relationship to Premature Adrenarche, Insulin Resistance and the Polycystic Ovary Syndrome

By Auchus R.J.   Geller D.H.   Lee T.C.   Miller W.L.  

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 2, 1998-02 ,pp. : 47-50

Elsevier

Access to resources Recommend Favorite

17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.

By Sahin Y   Keleştimur F  

Human Reproduction, Vol. 12, Iss. 5, 1997-05 ,pp. : 910-913

Oxford University Press

Access to resources Recommend Favorite

Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance

By Nawrocka Jolanta   Starczewski Andrzej  

Gynecological Endocrinology, Vol. 23, Iss. 4, 2007-04 ,pp. : 231-237

Informa Healthcare

Access to resources Recommend Favorite